|
|
|
|
|
|
|
MESSAGE _ENGLISH VERSION_
|
|
|
|
|
|
|
|
|
Shareholders controlling at least 5% of the votes at the General
Shareholders Meeting of Ryvu Therapeutics S.A. convened on June 25th,
2026
The Management Board of Ryvu Therapeutics S.A. with its registered
office in Krakow, Poland _"Company", "Ryvu"_ hereby announces that the
following shareholders controlled at least 5% of the vote at the General
Shareholders Meeting of the Company _"General Meeting"_ convened on June
25th, 2026:
1. Benevora Fundacja Rodzinna w organizacji: 3,982,160 shares of the
Company, which entitled them to exercise 7,482,160 votes, which
constituted respectively 38.04% of shares at the GM and 51.53% of votes
at the GM and 27.54% in the total number of votes.
2. Allianz Polska Otwarty Fundusz Emerytalny: 2,292,540 shares of the
Company, which entitled them to exercise 2,292,540 votes, which
constituted respectively 21.90% of shares at the GM and 15.79% of votes
at the GM and 8.44% in the total number of votes.
3. Nationale-Nederlanden Otwarty Fundusz Emerytalny: 1,385,000 shares of
the Company, which entitled them to exercise 1,385,000 votes, which
constituted respectively 13.23% of shares at the GM and 9.54% of votes
at the GM and 5.10% in the total number of votes.
4. Capitals Fundacja Rodzinna w organizacji: 825,348 shares of the
Company, which entitled them to exercise 1,375,348 votes, which
constituted respectively 7.88% of shares at the GM and 9.47% of votes at
the GM and 5.06% in the total number of votes.
5. Otwarty Fundusz Emerytalny PZU Złota Jesień: 1,317,374 shares of the
Company, which entitled them to exercise 1,317,374 votes, which
constituted respectively 12.58% of shares at the GM and 9.07% of votes
at the GM and 4.85% in the total number of votes.
According to the attendance list, shareholders holding 10,469,494 shares
entitling them to exercise 14,519,494 votes were represented at the GM.
The total number of shares in the Company is 23,120,148, entitling to
27,170,148 votes.
Disclaimer: This English language translation has been prepared solely
for the convenience of English speaking readers. Despite all the efforts
devoted to this translation, certain discrepancies, omissions or
approximations may exist. In case of any differences between the Polish
and the English versions, the Polish version shall prevail. Ryvu
Therapeutics S.A., its representatives and employees decline all
responsibility in this regard.
|
|
|
|
|
|
|
|
RB: Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Walnym
Zgromadzeniu Ryvu Therapeutics S.A. w dniu 25 czerwca 2026 r. / Shareholders controlling
at least 5% of the votes at the General Shareholders Meeting of Ryvu Therapeutics
S.A. convened on June 25th, 2026
